A 45-year-old woman with stage 5 chronic kidney disease (CKD) due to lupus nephritis visits the nephrology clinic for routine follow-up. She has no overt ...

A cross-sectional study evaluated if the mode of sexual orientation and gender identification disclosure was associated with receiving clinical resources tailored to LGBTQ+ cancer survivors. A ...

Adverse changes in the heart’s structure and function are common in people with chronic kidney disease (CKD), warranting mitigating therapies.

However, myocardial infarction risk and cerebrovascular accident risk higher in transgender men compared with general population of women.

Consumption of one cup per day linked to less recurrence of atrial fibrillation or atrial flutter compared with abstinence.

The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.

Review shows modest benefit on sperm motility and morphology with lifestyle interventions, but not bariatric surgery.

Based on patterns of recurrence-free survival (RFS) over time in some studies, the researchers determined that 5-year RFS may be a suitable surrogate for measuring cure. In considering outcomes for ...

No significant difference seen in composite outcome of stroke, systemic embolism, new covert embolic stroke.

Benefits seen particularly for younger patients and for reducing racial disparities in access to kidney transplants.

Risk for progression to composite outcome did not differ across age groups for patients with MCD, FSGS, and MN.

The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.